Objectives To determine whether stress is associated with risk of bacterial vaginosis (BV) in pregnant women.Design Prospective cohort study.Setting The prenatal care clinics at the University of North Carolina. The residents' clinic sees mostly government-insured and uninsured women, and the physicians' clinic sees mostly those with private health insurance.Population A total of 897 women gave samples for BV analysis. Study participants were 22% African-American, 68% white; 24% unmarried and 44% nulliparous. More than half had completed college.Methods Women completed two questionnaires and two interviews reporting stress and psychological aspects of their lives. Measurement scales included the Sarason life events questionnaire, the Cohen perceived stress scale, Spielberger state-trait anxiety, the John Henryism coping style and the Medical Outcomes Study social support inventory. Two stress hormones, corticotrophinreleasing hormone and cortisol, were also measured.Main outcome measures BV at 15-19 and 24-29 weeks of gestation was diagnosed by Gram's stain.Results Women in the highest quartile of stress measures, particularly state anxiety (OR = 2.0, 95% CI 1.2-3.3), perceived stress (OR = 2.4, 95% CI 1.5-3.9) and total life events (OR = 2.0, 95% CI 1.3-3.2), had the highest risk of BV. Adjustment for confounders, especially age, race, and income, reduced these associations (state anxiety: OR = 1.3, 95% CI 0.7-2.4; perceived stress: OR = 1.4, 95% CI 0.8-2.5; total life events: OR = 1.3, 95% CI 0.7-2.4). No clear pattern of association was seen between stress hormones and BV.Conclusions Few associations between stress and BV were seen after adjustment for confounders.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.